[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] Contaminated heparin - 62 deaths in USA


  • From: "E-drug" <e-drug@healthnet.org>
  • Date: Sat, 12 Apr 2008 00:03:46 +0200

E-DRUG: Contaminated heparin - 62 deaths in USA
-----------------------------------------------

[Copied as fair use; WB]

http://www.washingtonpost.com/wp-dyn/content/article/2008/04/08/AR2008040803
032.html

FDA Raises Estimate of Deaths Linked to Blood Thinner
By Marc Kaufman
Washington Post Staff Writer
Wednesday, April 9, 2008; Page A03

The Food and Drug Administration yesterday raised from 19 to 62 its estimate
of the number of people who may have died after having allergic reactions to
contaminated Chinese-produced batches of the blood thinner heparin.

The new statistics on fatalities, which the FDA had promised for weeks, were
posted on the agency's Web site.

The posting said that the reports of allergic reactions or low blood
pressure after the administration of heparin do not mean the drug was the
cause of death "in all cases." But the agency provided comparison statistics
showing that in 2006, three people were reported to have died following
allergic reactions to heparin.

In addition, FDA's month-by-month count of adverse-event reports involving
heparin showed that 47 of the 62 deaths associated with allergic reactions
occurred from November through February.

The FDA said it had received reports of 103 people who died after receiving
heparin last year, 62 of whom experienced an allergic reaction or a plunge
in blood pressure. The others showed no signs of allergic reaction.

Erin Gardiner, spokeswoman for Baxter International, which distributed the
contaminated heparin, said last night that the company had received reports
of 38 deaths associated with the drug, but its officials maintain that four
of those were the result of unexplained allergic reactions. The rest of the
reported deaths, Gardiner said, were not associated with Baxter's heparin,
were probably caused by other illnesses or conditions, or were based on
information too cursory to be proved one way or the other.

The increase in reports of suspected heparin fatalities does not mean that
people are still being harmed by the drug. The contaminated Baxter heparin
was taken off the market several months ago, but earlier cases are still
being reported and investigated.

Heparin, which is made from a compound found in pig intestines, has been
widely used for decades during surgery and kidney dialysis.

FDA officials have said that some Chinese-produced heparin and active
ingredients used to make it were contaminated with a substance that
chemically resembles heparin but was different enough to have caused the
sudden spike in allergic reactions.

In previous statements, the agency said it did not know whether the cheaper
contaminant -- which may have come from pig cartilage -- was deliberately
added to the crude heparin or was the result of a production problem.

China is now the world's largest producer of the raw ingredients in heparin.
The contaminated batches of the drug have increased concerns among lawmakers
and the public about the globalization of drug-manufacturing in lightly
regulated nations. In response to criticism that it was not properly
overseeing Chinese companies that make drugs for American patients, the FDA
recently announced that it would soon open its first office there.

It took sophisticated, never-before-used tests to detect the contaminated
heparin, and identifying the contaminant as a form of chondroitin sulfate
took additional weeks of laboratory work.